Cyproheptadine Hydrochloride Syrup — Class III drug recall D-1062-2016
Terminated recall by Lyne Laboratories, Inc., reported 2016-07-13, distributed in NJ. Subpotency: product assayed and found OOS for cyproheptadine
| Recall number | D-1062-2016 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lyne Laboratories, Inc., Brockton, MA, United States |
| Recall initiated | 2016-06-07 |
| Classified | 2016-07-05 |
| Reported by FDA | 2016-07-13 |
| Terminated | 2017-02-03 |
| Distributed | NJ |
| Quantity | 12,215 bottles |
| Reason classes | specification failure |
| NDC | 64980-0504-48 |
| Lot numbers | 12/17, CR1603 |
Product
Cyproheptadine Hydrochloride Syrup, Oral Solution USP, 2 mg/5 mL, packaged in an amber glass 473 mL (one pint) bottle with child-resistant screw closure, Rx only, Distributed by: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Manufactured by: Lyne Laboratories, Inc., Brockton, MA 02301, NDC 64980-0504-48
Reason for recall
Subpotency: product assayed and found OOS for cyproheptadine
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1062-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.